Impact of a Soft Robotic Exoskeleton on Gait Rehabilitation Outcomes in Individuals with Parkinson's Disease: A Randomized Controlled Pilot Investigation - Top-Institutions - MDSpire

Impact of a Soft Robotic Exoskeleton on Gait Rehabilitation Outcomes in Individuals with Parkinson's Disease: A Randomized Controlled Pilot Investigation

  • By

  • Shiying Bu

  • Xiaoqing Luo

  • Shuangfang Li

  • Yuqin Shi

  • Lingjing Jin

  • Qing Zhao

  • April 28, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Movement Disorders
    • Rehabilitation Medicine

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neuroscience Research
    • Physical Medicine and Rehabilitation

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Biomedical Engineering
    • Rehabilitation Medicine

  • #4

    Massachusetts General Hospital (MGH) / Harvard Medical School
    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neurology
    • Movement Disorders
    • Physical Therapy

  • #5

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Neurology
    • Rehabilitation Medicine
    • Robotics

Original Source(s)

Impact of a Soft Robotic Exoskeleton on Gait Rehabilitation Outcomes in Individuals with Parkinson's Disease: A Randomized Controlled Pilot Investigation

  • by Shiying Bu, Xiaoqing Luo, Shuangfang Li, Yuqin Shi, Lingjing Jin, Qing Zhao

  • April 28, 2026

Related Content

Anti-diabetic medications to fight Parkinson's disease and dementia with Lewy bodies: a pilot study

This Week’s CGT News: Novo’s Parkinson’s Pivot

Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward

  • May 18, 2026

  • 7 min
Balancing benefits and challenges of eHealth for family caregivers of people with Parkinson’s disease – A qualitative study